Review on Persistent Threat of Monkeypox

Year : 2024 | Volume : 14 | Issue : 03 | Page : 37 42
    By

    Ali S. Shakir,

  • Zainab H.Al-zubaidy,

  • Ghofran K. Al-khafajia,

  1. Lecturer Clinical Immunology, College of Dentistry, University of Al-Qadisiyah, Diwaniyah, , Iraq
  2. Lecturer Medical Microbiology, College of Dentistry, University of Babylon, Baghdad, , Iraq
  3. Faculty of Pharmacy, Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences, Al-Najaf, , Iraq

Abstract

Monkeypox virus (at this instant notorious as MPXV, the virus that sources the lately rechristened infection monkeypox) was learned at Denmark’s State Serum Organization in 1958, which is closely like smallpox. For the next 50 years, monkeypox was primarily confined to tiny, sporadic epidemics in western and central Africa. These epidemics were primarily caused by spillover episodes, in which the virus sprang through a host animal to a human, followed by limited human-to-human transmission among intimate contacts. Outbreaks transpired externally of these positions, principally because of collapsibility or experience to smuggle and catch environment. In May 2022, the comprehensive layout and epidemiology of monkeypox improved. Some countries in Cowboy movie Europe and Arctic America, partaking no preceding involvement through Cowboy movie diffusion, initiated reporting suitcases. Over the subsequent binary months, the sickness rapidly prolonged to virtually every mainland, using over 7000 inveterate circumstances. What correspondingly dreadful was the inordinate popular of the archive’s broadcasts befallen concluded sexual or nearby cherished relations, primarily impacting gangs who are gay, besides/or sex through male’s elderly 18–44 years ancient. Earlier epidemics were frequently instigated by spillover affairs, with trifling confirmation of fragmentary, hominid-to-social. In rejoinder, strength officialdoms near the creation represented swiftly. The World Health Organization issued a global public health urgent, while in United States department health of human services labeled in 2022 monkeypox epidemic as a crisis for public health. Although the outbreak appeared to peak swiftly and then decline, new cases continued to emerge. Via December 2022, tabloid occasions in the United States had alleviated at exceptionally truncated stages, but the infection consumed not been destroyed. Now, nearly two years later, some cities continue to see as many as 50 additional reported cases every month. Furthermore, wastewater surveillance data revealed irregular areas with intermittent detection

Keywords: Health , Monkeypox virus, MPXV, Mpox

[This article belongs to Research & Reviews: A Journal of Microbiology & Virology ]

How to cite this article:
Ali S. Shakir, Zainab H.Al-zubaidy, Ghofran K. Al-khafajia. Review on Persistent Threat of Monkeypox. Research & Reviews: A Journal of Microbiology & Virology. 2024; 14(03):37-42.
How to cite this URL:
Ali S. Shakir, Zainab H.Al-zubaidy, Ghofran K. Al-khafajia. Review on Persistent Threat of Monkeypox. Research & Reviews: A Journal of Microbiology & Virology. 2024; 14(03):37-42. Available from: https://journals.stmjournals.com/rrjomv/article=2024/view=177412


References

  1. WHO-World Health Organization. (2022). Multi-country monkeypox outbreak in non-endemic countries [Accessed on 30 May 2022].
  2. Centers for Disease Control and Prevention (CDC). (2022). Monkeypox Outbreak Global Map [Accessed on 10 September 2022].
  3. (2022). World Health Organization WHO Director-General’s Statement at the Press Conference Following IHR Emergency Committee Regarding the Multi-Country Outbreak of Monkeypox [Accessed on 25 July 2022].
  4. Sklenovská N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health. 2018;6:241.
  5. Magnus PV, Andersen EK, Petersen KB, Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Pathol Microbiol Scand. 1959;46:156–176.
  6. Arita I, Gispen R, Kalter SS, Wah LT, Marennikova SS, Netter R, et al. Outbreaks of monkeypox and serological surveys in nonhuman primates. Bull World Health Organ. 1972;46:625–631.
  7. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull. World Health Organ. 1972;46:593–597.
  8. Rezza G. Emergence of human monkeypox in west Africa. Lancet Infect Dis. 2019;19:797–799. doi: 10.1016/S1473-3099(19)30281-6
  9. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox—a potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16:e0010141.
  10. Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Extended Human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerg Infect Dis. 2016;22:1014–1021.
  11. Hammarlund E, Lewis MW, Carter SV, Amanna I, Hansen SG, Strelow LI, et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005;11:1005–1011.
  12. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the western hemisphere. N Engl J Med. 2004;350:342–350.
  13. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019;13:e0007791.
  14. Rimoin Anne W, Mulembakani Prime M, Johnston Sara C, Lloyd Smith James O, Kisalu Neville K, Kinkela Timothee L, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA. 2010;107:16262–16267.
  15. Petersen BW, Kabamba J, McCollum AM, Lushima RS, Wemakoy EO, Muyembe Tamfum J-J, et al. Vaccinating against monkeypox in the Democratic Republic of the Congo. Antivir Res. 2019;162:171–177.
  16. Khodakevich L, Szczeniowski M, Nambu-ma D, Jezek Z, Marennikova S, Nakano J, et al. Monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone, Zaire. Trop Geogr Med. 1987;39:56–63.
  17. Haider N, Guitian J, Simons D, Asogun D, Ansumana R, Honeyborne I, et al. Increased outbreaks of monkeypox highlight gaps in actual disease burden in sub-Saharan Africa and in animal reservoirs. Int J Infect Dis. 2022;122:107–111.
  18. Al-Jassas SSA-H, Jwad SM. A physiological, histological evaluation study of erythropoietin hormone levels and some other biomarkers in male albino rats treated with acetaminophen drug and alcoholic extract of Malus domestica peels, Al-Harf J. 2024; 21.
  19. Mathieu E, Dattani S, Ritchie H, Max R, Fiona S. Monkeypox: cumulative confirmed cases, by date of confirmation. 2022.
  20. Falendysz EA, Lopera JG, Doty JB, Nakazawa Y, Crill C, Lorenzsonn F, et al. Characterization of monkeypox virus infection in African rope squirrels (Funisciurus). PLoS Negl Trop Dis. 2017;11:e0005809.
  21. Radonić A, Metzger S, Dabrowski PW, Couacy-Hymann E, Schuenadel L, Kurth A, et al. Fatal monkeypox in wild-living sooty mangabey, Côte d’Ivoire, 2012. Emerg Infect Dis. 2014;20:1009–1011.
  22. Guagliardo SAJ, Monroe B, Moundjoa C, Athanase A, Okpu G, Burgado J, et al. Asymptomatic orthopoxvirus circulation in humans in the wake of a monkeypox outbreak among chimpanzees in Cameroon. Am J Trop Med Hyg. 2020;102:206.
  23. Kadhim HF, Al-Sultany AO. Study of pollen grain from different taxa in the Cucurbitaceae family, Al-Harf J. 2024; 22.
  24. De Baetselier I, Van Dijck C, Kenyon C, Coppens J, Michiels J, de Block T, et al. Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium. Nat Med. 2022;28(11):2288–2292.
  25. Grant R, Nguyen L-BL, Breban R. Modelling human-to-human transmission of monkeypox. Bull World Health Organ. 2020;98:638.
  26. Pittman PR, Martin JW, Kingebeni PM, Tamfum J-JM, Wan Q, Reynolds MG, et al.The Kole Human Monkeypox Infection Study Group. Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo. medRxiv. 2022.
  27. Hind AA, Samira KH. Isolation and identification of Proteus mirabilis bacteria from different clinical sources and investigation of some of their virulence factors, Al-Harf J. 2023; 18:148–160.
  28. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22:1153–1162.
  29. Shakir AS, Hamza AT. Association of vitamin D binding protein BP rs2282679 gene polymorphism and serum levels of vitamin D in patients with vitiligo. Res Rev J Biotech, 2024;14(2):20–27.
  30. Hobson G, Adamson J, Adler H, Firth R, Gould S, Houlihan C, et al. Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021. Euro Surveill. 2021;26(32):2100745.
  31. Rani N, Khurana M. Enzyme stability prediction using BERT and CNN-A deep learning approach for enhanced biocatalysis. Res Rev J Life Sci. 2024;14(02):19–35.
  32. Evaluation tumor necrosis factor-α (TNF- α) levels in patients with rheumatoid arthritis, Res Rev J Immun. 2024;14(2):32–38.
  33. Sharma, Mohanty. A perspective review on role of environmental pollutants in developing neurodegenerative diseases. Res Rev J Life Sci. 2024;14(02):1–18.
  34. Kantele EA, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin. 2019;33:1027–1043.
  35. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID, WHO. Smallpox and its eradication. Geneva: World Health Organization; 1988.
Regular Issue Subscription Review Article
Volume 14
Issue 03
Received 29/09/2024
Accepted 03/10/2024
Published 08/10/2024
386

Login


My IP

PlumX Metrics